Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sven Mahner

Showing results (321-330 of 455) with videos related to

Pageof 46
Sort By:
Frontiers in Oncology|May 17, 2023
RIPK1 and RIPK3 are positive prognosticators for cervical cancer patients and C2 ceramide can inhibit tumor cell proliferation <i>in vitro</i>Tilman L R Vogelsang, Verena Kast, Konstantin Bagnjuk, et al.
International Journal of Molecular Sciences|February 15, 2022
Regulatory T Cell Apoptosis during Preeclampsia May Be Prevented by Gal-2Sarah Meister, Laura Hahn, Susanne Beyer, et al.
Molecular Cancer|March 25, 2014
Ambivalent role of pFAK-Y397 in serous ovarian cancer--a study of the OVCAD consortiumStefanie Aust, Katharina Auer, Anna Bachmayr-Heyda, et al.
Journal of Cancer Research and Clinical Oncology|April 15, 2017
Increased trace amine-associated receptor 1 (TAAR1) expression is associated with a positive survival rate in patients with breast cancerAurelia Vattai, Elif Akyol, Christina Kuhn, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|May 2, 2021
The decidual expression of Interleukin-7 is upregulated in early pregnancy lossTheresa Vilsmaier, Niklas Amann, Sanja Löb, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 25, 2014
Gynecologic Cancer InterGroup (GCIG) consensus review for small cell carcinoma of the cervixToyomi Satoh, Yuji Takei, Isabelle Treilleux, et al.
Cells|September 28, 2021
The Platelet-Activating Factor Receptor's Association with the Outcome of Ovarian Cancer Patients and Its Experimental Inhibition by RupatadineEileen Deuster, Ivi Hysenaj, Maja Kahaly, et al.
BMC Cancer|February 8, 2018
Whole blood microRNAs as potential biomarkers in post-operative early breast cancer patientsMarianna Alunni-Fabbroni, Leonie Majunke, Elisabeth K Trapp, et al.
Oncology Reports|July 30, 2009
Neoadjuvant chemotherapy with carboplatin and docetaxel in advanced ovarian cancer--a prospective multicenter phase II trial (PRIMOVAR)Martin Pölcher, Sven Mahner, Olaf Ortmann, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 31, 2023
Quality of therapy in early ovarian cancer: results of the quality assurance program of the AGO Study GroupPauline Wimberger, Jacobus Pfisterer, Andreas du Bois, et al.
Pageof 46

Showing results (321-330 of 455) with videos related to

Sort By:
Pageof 46
Frontiers in Oncology|May 17, 2023
RIPK1 and RIPK3 are positive prognosticators for cervical cancer patients and C2 ceramide can inhibit tumor cell proliferation <i>in vitro</i>Tilman L R Vogelsang, Verena Kast, Konstantin Bagnjuk, et al.
International Journal of Molecular Sciences|February 15, 2022
Regulatory T Cell Apoptosis during Preeclampsia May Be Prevented by Gal-2Sarah Meister, Laura Hahn, Susanne Beyer, et al.
Molecular Cancer|March 25, 2014
Ambivalent role of pFAK-Y397 in serous ovarian cancer--a study of the OVCAD consortiumStefanie Aust, Katharina Auer, Anna Bachmayr-Heyda, et al.
Journal of Cancer Research and Clinical Oncology|April 15, 2017
Increased trace amine-associated receptor 1 (TAAR1) expression is associated with a positive survival rate in patients with breast cancerAurelia Vattai, Elif Akyol, Christina Kuhn, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|May 2, 2021
The decidual expression of Interleukin-7 is upregulated in early pregnancy lossTheresa Vilsmaier, Niklas Amann, Sanja Löb, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 25, 2014
Gynecologic Cancer InterGroup (GCIG) consensus review for small cell carcinoma of the cervixToyomi Satoh, Yuji Takei, Isabelle Treilleux, et al.
Cells|September 28, 2021
The Platelet-Activating Factor Receptor's Association with the Outcome of Ovarian Cancer Patients and Its Experimental Inhibition by RupatadineEileen Deuster, Ivi Hysenaj, Maja Kahaly, et al.
BMC Cancer|February 8, 2018
Whole blood microRNAs as potential biomarkers in post-operative early breast cancer patientsMarianna Alunni-Fabbroni, Leonie Majunke, Elisabeth K Trapp, et al.
Oncology Reports|July 30, 2009
Neoadjuvant chemotherapy with carboplatin and docetaxel in advanced ovarian cancer--a prospective multicenter phase II trial (PRIMOVAR)Martin Pölcher, Sven Mahner, Olaf Ortmann, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 31, 2023
Quality of therapy in early ovarian cancer: results of the quality assurance program of the AGO Study GroupPauline Wimberger, Jacobus Pfisterer, Andreas du Bois, et al.
Pageof 46